Checkmate Pharmaceuticals, Inc. (CMPI) financial statements (2022 and earlier)

Company profile

Business Address 245 MAIN STREET, 2ND FLOOR
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:70,900125,900
Cash and cash equivalents50,67543,055
Short-term investments20,192 
Other undisclosed cash, cash equivalents, and short-term investments3382,845
Restricted cash and investments2020
Other undisclosed current assets3,042(23,819)
Total current assets:73,962102,101
Noncurrent Assets
Property, plant and equipment777 
Long-term investments and receivables 30,973
Long-term investments 30,973
Other noncurrent assets4,099 
Total noncurrent assets:4,87630,973
TOTAL ASSETS:78,838133,074
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities9,3797,875
Accounts payable3,3852,297
Accrued liabilities5,9945,578
Total current liabilities:9,3797,875
Noncurrent Liabilities
Total liabilities:9,3797,875
Stockholders' equity
Stockholders' equity attributable to parent69,459125,199
Common stock22
Additional paid in capital270,947265,342
Accumulated other comprehensive loss(14)(74)
Accumulated deficit(201,476)(140,071)
Total stockholders' equity:69,459125,199
TOTAL LIABILITIES AND EQUITY:78,838133,074

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
Operating expenses(61,470)(36,904)
Operating loss:(61,470)(36,904)
Nonoperating income (expense)65(4)
Investment income, nonoperating10079
Net loss attributable to parent:(61,405)(36,908)
Preferred stock dividends and other adjustments (5,997)
Net loss available to common stockholders, diluted:(61,405)(42,905)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
Net loss:(61,405)(36,908)
Comprehensive loss:(61,405)(36,908)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent60(74)
Comprehensive loss, net of tax, attributable to parent:(61,345)(36,982)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: